In Print

Photo by Graham Ramsay

Topical Treatment Quashes Herpes with RNAi
Using RNA interference, or RNAi, Judy Lieberman (left), Yichao Wu, and colleagues developed a treatment that KOs the herpesvirus with a molecular one–two punch. It disables the bug’s ability to replicate as well as the host cell’s ability to take up the virus. The research, conducted in mice, demonstrated that the therapy is effective when applied anywhere from one week before infection to a few hours after viral exposure. If the findings are successfully replicated in humans, people worldwide will have a new and powerful means of protecting themselves against this harmful pathogen.

Upcoming

Office for Diversity and Community Partnership

Black History Month Forum: Navigating the Past: Confronting Universities’ Historical Relationship to Slavery

Monday, Feb. 9
12:45–2:15 pm

Speaker:
• James Campbell

Student Scene

Photo by Graham Ramsay

Bringing Research Back to the People
While spending a summer at a South African hospital, Kristin Huang administered an infection-control questionnaire, but soon ran into resistance from the workers being surveyed. It turned out, they had little faith that there would be any response to their input.

StudenTalk

Personal takes on issues inside and outside the classroom.

Science Progress

How discovery happens.

Lab Works

A multimedia site featuring Harvard Medical research.